I had the pleasure of interviewing Christopher Oermann, MD, Director of the Cystic Fibrosis Care Center at Childrens Mercy Kansas City, about cystic fibrosis. Childrens Mercy Kansas City is one of the national centers for cystic fibrosis.
Cystic fibrosis treatment now includes an FDA-approved CFTR modulator, which has really been a game-changer. It's so exciting to see that basic medical research has finally resulted in a treatment that really makes a difference in patients' quality of life and longevity.
For the full story, you can listen to this 15-minute podcast, "Pediatrics in Practice."
For more fascinating interviews, please check out "The Art of Medicine with Dr. Andrew Wilner." It's available on your favorite podcast player as well as YouTube: www.youtube.com/c/andrewwilnermdauthor